• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. GlaxoSmithKline Says Salford Lung Study Has Positive Results

    GlaxoSmithKline Says Salford Lung Study Has Positive Results

  2. Global Respiratory Drugs Market 2016-2020 with AstraZeneca, Boehringer Ingelheim, F.Hoffman La-Roche, GlaxoSmithKline , Merck & Novartis Dominated - Research and Markets

    Global Respiratory Drugs Market 2016-2020 with AstraZeneca, Boehringer Ingelheim, F.Hoffman La-Roche, GlaxoSmithKline , Merck & Novartis Dominated - Research and Markets

  3. UPDATE: Jim O'Neill wants to offer $1 billion prizes for new antibiotics

    UPDATE: Jim O'Neill wants to offer $1 billion prizes for new antibiotics

  4. Jim O'Neill wants to offer $1 billion prizes for new drugs to fight lethal superbugs

    Jim O'Neill wants to offer $1 billion prizes for new drugs to fight lethal superbugs

  5. Global Vaccines Market Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: Merck, Pfizer, GlaxoSmithKline - Research and Markets

    Global Vaccines Market Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: Merck, Pfizer, GlaxoSmithKline - Research and Markets

  6. CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP

    CHAMPIX® (varenicline) European Union Label Updated to Include New Safety and Efficacy Data from the EAGLES Clinical Trial Following Endorsement from CHMP

  7. UPDATE: These high-yielding, dividend-paying stocks put money in your pocket

    UPDATE: These high-yielding, dividend-paying stocks put money in your pocket

  8. Neisseria Meningitidis Infections Pipeline Review, H1 2016 - 12 Companies & Their Drug Profiles - Research and Markets

    Neisseria Meningitidis Infections Pipeline Review, H1 2016 - 12 Companies & Their Drug Profiles - Research and Markets

  9. Chagas Disease (American Trypanosomiasis) Pipeline Review, H1 2016 - 10 Companies & Drug Profiles - Research and Markets

    Chagas Disease (American Trypanosomiasis) Pipeline Review, H1 2016 - 10 Companies & Drug Profiles - Research and Markets

  10. Novartis Says Drug-Unit Chief To Leave Firm -- WSJ

    Novartis Says Drug-Unit Chief To Leave Firm -- WSJ

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.